Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L2EQ
|
|||
Drug Name |
PMID25522065-Compound-7
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
ALBANY MOLECULAR RESEARCH, INC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C26H30N4O
|
|||
Canonical SMILES |
CN1C2=C(C3CCC(C2)N3)C4=C1C=C(C=C4)N5CCN(CC5=O)CCC6=CC=CC=C6
|
|||
InChI |
1S/C26H30N4O/c1-28-23-16-20(8-9-21(23)26-22-10-7-19(27-22)15-24(26)28)30-14-13-29(17-25(30)31)12-11-18-5-3-2-4-6-18/h2-6,8-9,16,19,22,27H,7,10-15,17H2,1H3
|
|||
InChIKey |
JXBCIEBMTZBYLB-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Melanin-concentrating hormone receptor 1 (MCHR1) | Target Info | Antagonist | [1] |
Target's Patent Info | Melanin-concentrating hormone receptor 1 (MCHR1) | Target's Patent Info | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Peptide ligand-binding receptors | |||
G alpha (q) signalling events | ||||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel MCH1 receptor antagonists: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):193-207. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.